Japan's medical device market is worth about $23.4 billion and is the second largest in the world, after the U.S. This article goes over some of the key factors in Japan's medical device market, including product registration, reimbursement approval and market entry... Read More
Despite the difficulties foreign companies sometimes face when entering the Japanese medical device market, strong demand for more technologically advanced products and sophisticated medical treatment has opened up the market more to manufacturers who can meet this demand. The Japanese government is... Read More
China's pharmaceutical market is booming, and with the formation of the State Drug Administration (SDA) in 1998, enforcement of pharmaceutical regulations has greatly improved. An increase in drug supervision, through stricter punishments for drug research, declaration and registration violations, was implemented by... Read More
The Japanese medical market is on the rebound and is expected to grow to 6% annually over the next several years. With 20% of the population over the age of 65 and a growing number of diseases like cancer and heart disease... Read More
With an average growth rate of about 18%-20% per year, China's pharmaceutical market is expected to be the world's largest market by the year 2020. Despite complexities within the Chinese system, including confusion over monitoring and approving certain drugs, and restructuring of... Read More
South Korea's medical market is the third largest in Asia and is worth almost $11 billion. The Asian financial crisis sparked a government reform effort in Korea to liberalize its markets, allowing more foreign investment opportunities, especially in the medical market. The... Read More
In the U.S., the culture and the civil negligence liability system dictates that doctors and hospitals disclose to prospective patients what the illness and proposed course of treatment are, including the benefits and risks. Generally speaking, patients in the U.S. and their... Read More
On November 1, 1994 Ronald Brown, U.S secretary of commerce, and Takakuzu Kuriyama, Japan's ambassador to the United States, signed the Medical Technology Arrangement (MTA). The agreement marked an important step opening to U.S. manufacturers Japan's public sector procurement market for medical... Read More
As the environment for importing medical devices into Japan changes, it is important for U.S. firms selling in Japan to understand the implications of the new rules and regulations for their products. Companies should include in their foreign market strategies regular and... Read More